Oncology Central

Creating chemotherapeutic-resistant breast cancer cell lines: advances and future perspectives


Breast cancer continues to be of critical clinical significance. Even after years of successful advancements in therapeutic options, it remains the second leading cause of cancer-related death in women. An estimated 40,000 women are expected to succumb to advanced, metastatic disease within the next calendar year [1]. Although the rates of breast cancer-related deaths have been declining, the high incidence of both tumor recurrence and metastasis make finding new and creative treatment methodologies essential to combating this complex, heterogeneous disease more effectively.

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.




News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.